Relmacabtagene autoleucel (relma-cel)

DRUG2 trials

Sponsors

Ruijin Hospital

Conditions

B-cell Non Hodgkin LymphomaDLBCL - Diffuse Large B Cell Lymphoma

Phase 2

CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors

RecruitingNCT06365671

Ruijin HospitalB-cell Non Hodgkin Lymphoma

Start: 2024-04-16End: 2027-04-30Target: 16Updated: 2026-01-06

Glofitamab Combined With CAR-T Therapy in R/R DLBCL

Not yet recruitingNCT07326371

Ruijin HospitalDLBCL - Diffuse Large B Cell Lymphoma

Start: 2026-03-31End: 2029-03-31Target: 24Updated: 2026-01-08